Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v15-FR Version v8-EN
Language French English
Date Updated 2020-07-06 2020-03-31
Drug Identification Number 02393492 02393492
Brand name APO-RIZATRIPTAN RPD APO-RIZATRIPTAN RPD
Common or Proper name RIZATRIPTAN RIZATRIPTAN
Company Name APOTEX INC APOTEX INC
Ingredients RIZATRIPTAN RIZATRIPTAN
Strength(s) 10MG 10MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL ORAL
Packaging size 6 BLS 6 BLS
ATC code N02CC N02CC
ATC description ANTIMIGRAINE PREPARATIONS ANTIMIGRAINE PREPARATIONS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2014-10-01 2014-10-01
Estimated end date 2020-07-03 2020-06-05
Actual end date 2019-04-05
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Product was discontinued
Health Canada comments